发明名称 |
Phytoestrogen product of red clover and pharmaceutical uses thereof |
摘要 |
The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating bone remodeling, and prevention and treatment of osteoporosis. |
申请公布号 |
US9333192(B2) |
申请公布日期 |
2016.05.10 |
申请号 |
US201414242981 |
申请日期 |
2014.04.02 |
申请人 |
SINOVEDA CANADA, INC |
发明人 |
Tam Yun Kau;Lin Yi-Chan James;Sloley Brian Duff;Tseng Chih-Yuan |
分类号 |
A61K31/353;A61K36/48;G06F19/00 |
主分类号 |
A61K31/353 |
代理机构 |
Law Offices of Albert Wai-Kit Chan, PLLC |
代理人 |
Law Offices of Albert Wai-Kit Chan, PLLC |
主权项 |
1. An in vitro method of enhancing osteoblast differentiation, comprising the step of contacting osteoblasts with a composition comprising biochanin A and genistein, wherein the ratio of biochanin A to genistein is 9:1, and the composition comprises a dosage of total phytoestrogens ranging from 1 to 10 mg, wherein the concentration of biochanin A is 9 μM and the concentration of genistein is 1 μM. |
地址 |
CA US |